De Socio, Giuseppe Vittorio Luigi and Bonfanti, Paolo and Ricci, Elena and Orofino, Giancarlo and Madeddu, Giordano and Penco, Giovanni and Gianelli, Erika and Martinelli, Canio and Carradori, Silvia and Quirino, Tiziana and Rizzardini, Giuliano (2008) Cholesterol levels in HIV–HCV infected patients treated with lopinavir/r: results from the SCOLTA project. Biomedicine & Pharmacotherapy, Vol. 62 (1), p. 16-20. ISSN 0753-3322. Article.
Full text not available from this repository.
Background. It is not known whether antiretroviral therapy (ART) including lopinavir/r has a different effect on the lipid metabolism in HIV patients co-infected with HCV. This study investigated changes in lipid levels, comparing patients with HIV infection alone and those with HCV too, in the lopinavir/r cohort of the SCOLTA project.
Methods. We analyzed the data for the lopinavir/r nationwide cohort from 25 Italian infectious disease departments, which comprises 743 HIV-infected patients followed prospectively, comparing subjects with HIV–HCV co-infection and those with single-infection.
Results. At enrolment, co-infected patients had significantly lower mean cholesterol than HCV negative cases (162 ± 43 mg/dL vs. 185 ± 52 mg/dL, p = 0.0009). Total and non-HDL cholesterol and triglycerides rose significantly from baseline in HIV single-infection patients, but not in those with co-infection. The patients with dual HIV–HCV infection, treated with an ART regimen including lopinavir/r, have only limited increases in total and non-HDL cholesterol and triglycerides.
Conclusions. Changes in serum lipids in co-infected patients differed significantly from those in patients without HCV. It remains to be seen whether this is associated with a lower risk of progression of atherosclerotic disease.
I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore
Repository Staff Only: item control page